EMEA Pitavastatin Market by Manufacturers, Regions, Type and Application, Forecast to 2022

March 2017 | 116 pages | ID: EDB7070E71BEN
GlobalInfoResearch

Abstracts

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

Scope of the Report:

This report focuses on the Pitavastatin in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• CR Double-Crane Pharmaceuticals
• Kowa Pharmaceuticals
Market Segment by Regions, regional analysis covers
• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
• 1 mg
• 2 mg
• 5 mg
Market Segment by Applications, can be divided into
• Hypercholesterolaemia
• Cardiovascular Disease
• Diabetes
• Others
There are 13 Chapters to deeply display the EMEA Pitavastatin market.

Chapter 1, to describe Pitavastatin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pitavastatin, with sales, revenue, and price of Pitavastatin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Pitavastatin, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Pitavastatin market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Pitavastatin research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Pitavastatin Introduction
1.2 Market Analysis by Type
  1.2.1 1 mg
  1.2.2 2 mg
  1.2.3 5 mg
1.3 Market Analysis by Applications
  1.3.1 Hypercholesterolaemia
  1.3.2 Cardiovascular Disease
  1.3.3 Diabetes
  1.3.4 Others
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CR Double-Crane Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Pitavastatin Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 CR Double-Crane Pharmaceuticals Pitavastatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Kowa Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Pitavastatin Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Kowa Pharmaceuticals Pitavastatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA PITAVASTATIN MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Pitavastatin Sales and Market Share by Manufacturer
3.2 EMEA Pitavastatin Revenue and Market Share by Manufacturer
3.3 EMEA Pitavastatin Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Pitavastatin Manufacturer Market Share
  3.4.2 Top 5 Pitavastatin Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA PITAVASTATIN MARKET ANALYSIS BY REGIONS

4.1 EMEA Pitavastatin Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Pitavastatin Sales by Regions (2012-2017)
  4.1.2 EMEA Pitavastatin Revenue by Regions (2012-2017)
4.2 Europe Pitavastatin Sales and Growth (2012-2017)
4.3 Middle East Pitavastatin Sales and Growth (2012-2017)
4.4 Africa Pitavastatin Sales and Growth (2012-2017)

5 EUROPE PITAVASTATIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Pitavastatin Sales, Revenue and Market Share by Countries
  5.1.1 Europe Pitavastatin Sales by Countries (2012-2017)
  5.1.2 Europe Pitavastatin Revenue by Countries (2012-2017)
  5.1.3 Germany Pitavastatin Sales and Growth (2012-2017)
  5.1.4 France Pitavastatin Sales and Growth (2012-2017)
  5.1.5 UK Pitavastatin Sales and Growth (2012-2017)
  5.1.6 Russia Pitavastatin Sales and Growth (2012-2017)
  5.1.7 Italy Pitavastatin Sales and Growth (2012-2017)
  5.1.8 Turkey Pitavastatin Sales and Growth (2012-2017)
5.2 Europe Pitavastatin Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Pitavastatin Sales by Manufacturers (2016-2017)
  5.2.2 Europe Pitavastatin Revenue by Manufacturers (2016-2017)
5.3 Europe Pitavastatin Sales by Type (2012-2017)
5.4 Europe Pitavastatin Sales by Application (2012-2017)

6 MIDDLE EAST PITAVASTATIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Pitavastatin Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Pitavastatin Sales by Countries (2012-2017)
  6.1.2 Middle East Pitavastatin Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Pitavastatin Sales and Growth (2012-2017)
  6.1.4 Israel Pitavastatin Sales and Growth (2012-2017)
  6.1.5 UAE Pitavastatin Sales and Growth (2012-2017)
  6.1.6 Iran Pitavastatin Sales and Growth (2012-2017)
6.2 Middle East Pitavastatin Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Pitavastatin Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Pitavastatin Revenue by Manufacturers (2016-2017)
6.3 Middle East Pitavastatin Sales by Type (2012-2017)
6.4 Middle East Pitavastatin Sales by Application (2012-2017)

7 AFRICA PITAVASTATIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Pitavastatin Sales, Revenue and Market Share by Countries
  7.1.1 Africa Pitavastatin Sales by Countries (2012-2017)
  7.1.2 Africa Pitavastatin Revenue by Countries (2012-2017)
  7.1.3 South Africa Pitavastatin Sales and Growth (2012-2017)
  7.1.4 Nigeria Pitavastatin Sales and Growth (2012-2017)
  7.1.5 Egypt Pitavastatin Sales and Growth (2012-2017)
  7.1.6 Algeria Pitavastatin Sales and Growth (2012-2017)
7.2 Middle East Pitavastatin Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Pitavastatin Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Pitavastatin Revenue by Manufacturers (2016-2017)
7.3 Middle East Pitavastatin Sales by Type (2012-2017)
7.4 Middle East Pitavastatin Sales by Application (2012-2017)

8 EMEA PITAVASTATIN MARKET SEGMENT BY TYPE

8.1 EMEA Pitavastatin Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Pitavastatin Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Pitavastatin Revenue and Market Share by Type (2012-2017)
8.2 1 mg Sales Growth and Price
  10.2.1 EMEA 1 mg Sales Growth (2012-2017)
  10.2.2 EMEA 1 mg Price (2012-2017)
8.3 2 mg Sales Growth and Price
  10.3.1 EMEA 2 mg Sales Growth (2012-2017)
  10.3.2 EMEA 2 mg Price (2012-2017)
8.4 5 mg Sales Growth and Price
  10.4.1 EMEA 5 mg Sales Growth (2012-2017)
  10.4.2 EMEA 5 mg Price (2012-2017)

9 EMEA PITAVASTATIN MARKET SEGMENT BY APPLICATION

9.1 EMEA Pitavastatin Sales Market Share by Application (2012-2017)
9.2 Hypercholesterolaemia Sales Growth (2012-2017)
9.3 Cardiovascular Disease Sales Growth (2012-2017)
9.4 Diabetes Sales Growth (2012-2017)
9.5 Others Sales Growth (2012-2017)

10 EMEA PITAVASTATIN MARKET FORECAST (2017-2022)

10.1 EMEA Pitavastatin Sales, Revenue and Growth Rate (2017-2022)
10.2 Pitavastatin Market Forecast by Regions (2017-2022)
  10.2.1 Europe Pitavastatin Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Pitavastatin Sales Forecast 2017-2022
    10.2.1.2 France Pitavastatin Sales Forecast 2017-2022
    10.2.1.3 UK Pitavastatin Sales Forecast 2017-2022
    10.2.1.4 Russia Pitavastatin Sales Forecast 2017-2022
    10.2.1.5 Italy Pitavastatin Sales Forecast 2017-2022
    10.2.1.6 Turkey Pitavastatin Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Pitavastatin Sales Forecast 2017-2022
    10.2.2.2 Israel Pitavastatin Sales Forecast 2017-2022
    10.2.2.3 UAE Pitavastatin Sales Forecast 2017-2022
    10.2.2.4 Iran Pitavastatin Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Pitavastatin Sales Forecast 2017-2022
    10.2.3.2 Nigeria Pitavastatin Sales Forecast 2017-2022
    10.2.3.3 Egypt Pitavastatin Sales Forecast 2017-2022
    10.2.3.4 Algeria Pitavastatin Sales Forecast 2017-2022
10.3 Pitavastatin Market Forecast by Type (2017-2022)
10.4 Pitavastatin Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Pitavastatin Picture
Table Product Specifications of Pitavastatin
Figure EMEA Sales Market Share of Pitavastatin by Types in 2016
Table Pitavastatin Types for Major Manufacturers
Figure 1 mg Picture
Figure 2 mg Picture
Figure 5 mg Picture
Table Pitavastatin Sales Market Share by Applications in 2016
Figure Hypercholesterolaemia Picture
Figure Cardiovascular Disease Picture
Figure Diabetes Picture
Figure Others Picture
Figure Germany Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure France Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure UK Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Pitavastatin Revenue (Value) and Growth Rate (2012-2022)
Table CR Double-Crane Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table CR Double-Crane Pharmaceuticals Pitavastatin Type and Applications
Table CR Double-Crane Pharmaceuticals Pitavastatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kowa Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Kowa Pharmaceuticals Pitavastatin Type and Applications
Table Kowa Pharmaceuticals Pitavastatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Pitavastatin Sales by Manufacturer (2016-2017)
Figure EMEA Pitavastatin Sales Market Share by Manufacturer in 2016
Figure EMEA Pitavastatin Sales Market Share by Manufacturer in 2017
Table EMEA Pitavastatin Revenue by Manufacturer (2016-2017)
Figure EMEA Pitavastatin Revenue Market Share by Manufacturer in 2016
Figure EMEA Pitavastatin Revenue Market Share by Manufacturer in 2017
Table EMEA Pitavastatin Price by Manufacturer (2016-2017)
Figure EMEA Pitavastatin Sales and Growth (2012-2017)
Figure EMEA Pitavastatin Revenue and Growth (2012-2017)
Table EMEA Pitavastatin Sales by Regions (2012-2017)
Table EMEA Pitavastatin Sales Market Share by Regions (2012-2017)
Figure EMEA Pitavastatin Sales Market Share by Regions in 2012
Figure EMEA Pitavastatin Sales Market Share by Regions in 2016
Table EMEA Pitavastatin Revenue by Regions (2012-2017)
Table EMEA Pitavastatin Revenue Market Share by Regions (2012-2017)
Figure EMEA Pitavastatin Revenue Market Share by Regions in 2012
Figure EMEA Pitavastatin Revenue Market Share by Regions in 2016
Figure Europe Pitavastatin Sales and Growth (2012-2017)
Figure Middle East Pitavastatin Sales and Growth (2012-2017)
Figure Africa Pitavastatin Sales and Growth (2012-2017)
Figure Europe Pitavastatin Revenue and Growth (2012-2017)
Table Europe Pitavastatin Sales by Countries (2012-2017)
Table Europe Pitavastatin Sales Market Share by Countries (2012-2017)
Figure Europe Pitavastatin Sales Market Share by Countries in 2012
Figure Europe Pitavastatin Sales Market Share by Countries in 2016
Table Europe Pitavastatin Revenue by Countries (2012-2017)
Table Europe Pitavastatin Revenue Market Share by Countries (2012-2017)
Figure Europe Pitavastatin Revenue Market Share by Countries in 2012
Figure Europe Pitavastatin Revenue Market Share by Countries in 2016
Figure Germany Pitavastatin Sales and Growth (2012-2017)
Figure France Pitavastatin Sales and Growth (2012-2017)
Figure UK Pitavastatin Sales and Growth (2012-2017)
Figure Russia Pitavastatin Sales and Growth (2012-2017)
Figure Italy Pitavastatin Sales and Growth (2012-2017)
Figure Turkey Pitavastatin Sales and Growth (2012-2017)
Table Europe Pitavastatin Sales by Manufacturer (2016-2017)
Figure Europe Pitavastatin Sales Market Share by Manufacturer in 2016
Figure Europe Pitavastatin Sales Market Share by Manufacturer in 2017
Table Europe Pitavastatin Revenue by Manufacturer (2016-2017)
Figure Europe Pitavastatin Revenue Market Share by Manufacturer in 2016
Figure Europe Pitavastatin Revenue Market Share by Manufacturer in 2017
Table Europe Pitavastatin Sales by Type (2012-2017)
Table Europe Pitavastatin Sales Share by Type (2012-2017)
Table Europe Pitavastatin Sales by Application (2012-2017)
Table Europe Pitavastatin Sales Share by Application (2012-2017)
Figure Middle East Pitavastatin Revenue and Growth (2012-2017)
Table Middle East Pitavastatin Sales by Countries (2012-2017)
Table Middle East Pitavastatin Sales Market Share by Countries (2012-2017)
Figure Middle East Pitavastatin Sales Market Share by Countries in 2012
Figure Middle East Pitavastatin Sales Market Share by Countries in 2016
Table Middle East Pitavastatin Revenue by Countries (2012-2017)
Table Middle East Pitavastatin Revenue Market Share by Countries (2012-2017)
Figure Middle East Pitavastatin Revenue Market Share by Countries in 2012
Figure Middle East Pitavastatin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pitavastatin Sales and Growth (2012-2017)
Figure Israel Pitavastatin Sales and Growth (2012-2017)
Figure UAE Pitavastatin Sales and Growth (2012-2017)
Figure Iran Pitavastatin Sales and Growth (2012-2017)
Table Middle East Pitavastatin Sales by Manufacturer (2016-2017)
Figure Middle East Pitavastatin Sales Market Share by Manufacturer in 2016
Figure Middle East Pitavastatin Sales Market Share by Manufacturer in 2017
Table Middle East Pitavastatin Revenue by Manufacturer (2016-2017)
Figure Middle East Pitavastatin Revenue Market Share by Manufacturer in 2016
Figure Middle East Pitavastatin Revenue Market Share by Manufacturer in 2017
Table Middle East Pitavastatin Sales by Type (2012-2017)
Table Middle East Pitavastatin Sales Share by Type (2012-2017)
Table Middle East Pitavastatin Sales by Application (2012-2017)
Table Middle East Pitavastatin Sales Share by Application (2012-2017)
Figure Africa Pitavastatin Revenue and Growth (2012-2017)
Table Africa Pitavastatin Sales by Countries (2012-2017)
Table Africa Pitavastatin Sales Market Share by Countries (2012-2017)
Figure Africa Pitavastatin Sales Market Share by Countries in 2012
Figure Africa Pitavastatin Sales Market Share by Countries in 2016
Table Africa Pitavastatin Revenue by Countries (2012-2017)
Table Africa Pitavastatin Revenue Market Share by Countries (2012-2017)
Figure Africa Pitavastatin Revenue Market Share by Countries in 2012
Figure Africa Pitavastatin Revenue Market Share by Countries in 2016
Figure South Africa Pitavastatin Sales and Growth (2012-2017)
Figure Nigeria Pitavastatin Sales and Growth (2012-2017)
Figure Egypt Pitavastatin Sales and Growth (2012-2017)
Figure Algeria Pitavastatin Sales and Growth (2012-2017)
Table Middle East Pitavastatin Sales by Manufacturer (2016-2017)
Figure Middle East Pitavastatin Sales Market Share by Manufacturer in 2016
Figure Middle East Pitavastatin Sales Market Share by Manufacturer in 2017
Table Middle East Pitavastatin Revenue by Manufacturer (2016-2017)
Figure Middle East Pitavastatin Revenue Market Share by Manufacturer in 2016
Figure Middle East Pitavastatin Revenue Market Share by Manufacturer in 2017
Table Middle East Pitavastatin Sales by Type (2012-2017)
Table Middle East Pitavastatin Sales Share by Type (2012-2017)
Table Middle East Pitavastatin Sales by Application (2012-2017)
Table Middle East Pitavastatin Sales Share by Application (2012-2017)
Table EMEA Pitavastatin Sales by Type (2012-2017)
Table EMEA Pitavastatin Sales Share by Type (2012-2017)
Table EMEA Pitavastatin Revenue by Type (2012-2017)
Table EMEA Pitavastatin Revenue Share by Type (2012-2017)
Figure EMEA 1 mg Sales Growth (2012-2017)
Figure EMEA 1 mg Price (2012-2017)
Figure EMEA 2 mg Sales Growth (2012-2017)
Figure EMEA 2 mg Price (2012-2017)
Figure EMEA 5 mg Sales Growth (2012-2017)
Figure EMEA 5 mg Price (2012-2017)
Table EMEA Pitavastatin Sales by Application (2012-2017)
Table EMEA Pitavastatin Sales Share by Application (2012-2017)
Figure EMEA Hypercholesterolaemia Sales Growth (2012-2017)
Figure EMEA Cardiovascular Disease Sales Growth (2012-2017)
Figure EMEA Diabetes Sales Growth (2012-2017)
Figure EMEA Others Sales Growth (2012-2017)
Figure EMEA Pitavastatin Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Pitavastatin Sales Forecast by Regions (2017-2022)
Table EMEA Pitavastatin Market Share Forecast by Regions (2017-2022)
Table Europe Pitavastatin Sales Forecast by Regions (2017-2022)
Figure Germany Pitavastatin Sales Forecast 2017-2022
Figure France Pitavastatin Sales Forecast 2017-2022
Figure UK Pitavastatin Sales Forecast 2017-2022
Figure Russia Pitavastatin Sales Forecast 2017-2022
Figure Italy Pitavastatin Sales Forecast 2017-2022
Figure Turkey Pitavastatin Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Pitavastatin Sales Forecast 2017-2022
Figure Israel Pitavastatin Sales Forecast 2017-2022
Figure UAE Pitavastatin Sales Forecast 2017-2022
Figure Iran Pitavastatin Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Pitavastatin Sales Forecast 2017-2022
Figure Nigeria Pitavastatin Sales Forecast 2017-2022
Figure Egypt Pitavastatin Sales Forecast 2017-2022
Figure Algeria Pitavastatin Sales Forecast 2017-2022
Table EMEA Pitavastatin Sales Forecast by Type (2017-2022)
Table EMEA Pitavastatin Market Share Forecast by Type (2017-2022)
Table EMEA Pitavastatin Sales Forecast by Application (2017-2022)
Table EMEA Pitavastatin Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List